Signature Resources Capital Management »

Carisma Therapeutics shares owned by Signature Resources Capital Management

Quarter-by-quarter ownership of Carisma Therapeutics (CARM) shares owned by Signature Resources Capital Management from 13F filings

Historical chart of Signature Resources Capital Management investment in Carisma Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Carisma Therapeutics held by Signature Resources Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carisma Therapeutics by Signature Resources Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $41 14 2.93
2023-12-31 $41 14 2.93

More positions owned by Signature Resources Capital Management

American Centy Etf Tr Us Eqt Etf (AVUS)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Short Duration F (DFSD)
Dimensional Etf Trust Intl Core Equity (DFIC)
American Centy Etf Tr Intl Eqt Etf (AVDE)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Dimensional Etf Trust Us Real Estate E (DFAR)
Lam Research Corporation (LRCX)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Alphabet Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for Signature Resources Capital Management

Top funds holding Carisma Therapeutics

Tpg Gp A
Vanguard Group
Bank of New York Mellon
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
Bank of America Corporation
Barclays
Rhumbline Advisers
UBS Group
Dimensional Fund Advisors
Blodgett Wealth Advisors
Two Sigma Investments
Jpmorgan Chase & Co
SG Americas Securities
American International

View all funds holding Carisma Therapeutics